Home/Committee Members/Dr. Raed Alroughani

Dr. Raed Alroughani

Consultant Neurologist, Director of MS Clinic
Kuwait City, Kuwait

Dr. Raed Alroughani
Dr. Raed AlroughaniSecretary General

Raed Alroughani received a degree in medicine from Charles University. He finished his neurology residency from the University of British Columbia and obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then completed a fellowship in demyelinating disorders at the University of British Columbia. Dr. Alroguhani is an active fellow of the American Academy of Neurology. He worked as a Consultant Neurologist at the Royal Columbian Hospital (Canada), after which he joined the division of neurology at Amiri Hospital (Kuwait). He established the first multi-disciplinary MS clinic at Dasman Research Institute in 2011. He currently serves as a Director of MS clinic in Dasman Research Institute and as a Head of MS Clinic at Ibn-Sina Hospital.

Dr. Alroughani’s fields of interest are principally directed towards the epidemiology and therapeutics of multiple sclerosis. He established the first national MS registry in Kuwait. He currently served as a principle investigator in various phase II / III / IV clinical trials and in MSBase which is the largest international MS registry including more than 60 countries. He is actively involved in research and he authored and co-authored more than 50 papers in the last 3 years.

Dr. Alroughani served as a member of the joint ethical committee formed by Kuwait University and Ministry of Health. He is the Past Treasurer of the Kuwait Neurological Society. He is a Board Member of the Neurology Residency examination committee in Kuwait. He is a board member in the Scientific Leadership Group of MSBase. He currently sits on the executive boards of various scientific associations, steering committees and advisory boards, mainly in the field of MS.

About Us

MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS).

Know our Organization